Hints and tips:
...Thomas (Mathew Baynton) is waiting to be kissed under the mistletoe, while Lady Fanny (Martha Howe-Douglas) wants a decent tree and Alison (Charlotte Ritchie) yearns to sing carols....
...In reality, two of the convicted officers, Clint Lorance and Mathew Golsteyn, killed defenceless civilians....
...A 2009 Supreme Court case involving prescription drug labels, Wyeth v Levine, greenlighted state laws that are stricter than federal laws....
...In December 2015, SAC paid $10m to investors in Wyeth in another class action....
...Martoma had obtained non-public information about an experimental drug for Alzheimer’s that was being developed by listed companies Elan and Wyeth....
...He was accused by the SEC of failing to supervise Mr Steinberg and another senior employee, Mathew Martoma, who was sentenced to nine years in prison in September....
...They are one of only two families to have three generations of work represented in the Smithsonian (the other is the Wyeth family of painters)....
...“Mathew Martoma and his family are devastated by the outcome,” they said in a statement released by the law firm Goodwin Procter....
...When the results were announced shares of Elan and Wyeth dropped. SAC made $276m in profits and avoided losses....
...Mathew Martoma “corrupted” medical doctors to gain an early look at confidential drug trial results that enabled hedge fund SAC Capital to make more than $276m in profits, prosecutors said as the trial over...
...“Mathew continues to fight the charges and is preparing for trial,” his lawyer Richard Strassberg said....
...They went back and forth over whether employees at Elan and Wyeth, co-developers of the experimental drug, had access to the data....
...A doctor briefed on a confidential Alzheimer’s drug trial testified on Wednesday that he was “flabbergasted” that Mathew Martoma, a former hedge fund manager at SAC, knew details about results only just...
...The following morning, a Monday, SAC dumped its entire $700m position in Wyeth and Elan, co-developers of the drug, and bet that their share prices would fall....
...US prosecutors said they were seeking $13.7m in cash plus the Florida home of Mathew Martoma, the former SAC Capital portfolio manager charged with allegedly participating in the most profitable insider...
...Mathew Martoma, a former SAC portfolio manager, was charged last year with trading shares of Wyeth and Elan, the two pharmaceutical companies sponsoring an Alzheimer drug trial, after receiving advance test...
...From Dr Peter V Mathews....
...The hedge fund has agreed a $602m settlement of civil charges with the SEC relating to trading in two pharmaceutical stocks, Elan and Wyeth, without admitting or denying wrongdoing....
...Mr Brown said SAC initially gave the government emails related to the trades in Elan and Wyeth before Mr Martoma was indicted....
...Three days later Steven Cohen, founder of SAC, began dumping the fund’s entire position in Elan and Wyeth....
...They alleged that he sold shares in drug companies Wyeth and Elan based on non-public information that indicated results of a clinical trial would be disappointing....
.../ From Mr Chris Bennett Adept left-handers in harmony with themselves / From Dr Peter V Mathews...
...the Analysts, Martoma claimed to have “black edge” —illicit, nonpublic information… The Analysts exchanged a number of emails and instant messages with Cohen about whether Martoma’s advice on Elan and Wyeth...
...The SEC shared its information with the FBI and US attorney’s office, which already had eyes on Mathew Martoma, a portfolio manager with SAC subsidiary CR Intrinsic, people familiar with the matter said....
...Meanwhile here’s the DOJ’s sealed criminal complaint in USA v Martoma....
International Edition